Monday, October 22, 2012
Sunday, October 21, 2012
Friday, October 19, 2012
Wednesday, October 17, 2012
Monday, October 15, 2012
Sunday, October 14, 2012
Wednesday, October 10, 2012
Value-based pricing is one potential solution to reduce the cost of drugs
A virtual monopoly held by some drug manufacturers in part because of the way treatment protocols work is among the reasons cancer drugs cost so much in the United States, according to a commentary by two Mayo Clinic physicians in the October issue of the journal Mayo Clinic Proceedings. Value-based pricing is one potential solution, they write.
Subscribe to:
Posts (Atom)